PMID: 9167335Nov 1, 1996Paper

Systemic complement activation in psoriasis vulgaris

Clinical and Experimental Dermatology
C J FlemingR M Mackie

Abstract

Nineteen patients with psoriasis vulgaris and no other cause for systemic complement activation were studied for evidence of such activation. There was a marked elevation in serum C5b-9 complexes with no other significant complement abnormalities, and no correlation between C5b-9 levels and disease activity. This is the most detailed study of complement in psoriasis yet attempted and confirms that complement activation is a feature of psoriasis vulgaris.

References

Jan 1, 1992·Dermatology : International Journal for Clinical and Investigative Dermatology·H Takematsu, H Tagami
Dec 1, 1990·The Journal of Investigative Dermatology·N Basset-SéguinK B Yancey
Jan 1, 1990·Clinical and Experimental Dermatology·E W RosenbergW P Kolb
Jan 1, 1989·Human Heredity·R J WyattE W Rosenberg
Jun 1, 1989·Blood Reviews·E R Holme, K Whaley
Aug 1, 1985·The British Journal of Dermatology·K OhkohchiH Tagami
Jan 1, 1983·Archives of Dermatological Research·G DewaldH W Kreysel
Jul 1, 1982·Clinical and Experimental Dermatology·W M MarleyR E Spitzer
Aug 1, 1995·Nature Medicine·L A Matis, S A Rollins
Jan 1, 1995·International Reviews of Immunology·M B Kahaleh

❮ Previous
Next ❯

Citations

Jan 23, 1999·Clinical and Experimental Dermatology·M PaschS S Asghar
Jun 20, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Quan-You ZhengShen-Ju Liang
May 2, 2018·Frontiers in Immunology·Jenny GiangJeffrey Damman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.